Navigation Links
Diplomat Specialty Pharmacy Hires Rinku A. Patel, PharmD as Director of Pharmacy Development and Operations

SWARTZ CREEK, Mich., Nov. 3 /PRNewswire/ -- Diplomat Specialty Pharmacy today announced that Dr. Rinku A. Patel has joined the company's executive management team. Dr. Patel will serve as Director of Pharmacy Development and Operations. She will be responsible for the management and development of Diplomat's Chicago location and will closely collaborate with the executive team to develop and implement specialty pharmacy programs. Dr. Patel will directly report to Jeff Rowe, Sr. Vice President of Operations for Diplomat.

"Rinku brings extensive expertise in several key growth areas for Diplomat including RSV, Hemophilia, and Pharmacy technology," said Phil Hagerman, President and CEO of Diplomat Specialty Pharmacy. "Her experience in these core Specialty Pharmacy areas will support our continued national expansion and industry leading platform."

"I am thrilled to be part of Diplomat. They are the largest independently owned specialty pharmacy in the country and value patient care above everything else," said Dr. Patel. "I am looking forward to providing innovative and comprehensive specialty pharmacy solutions to address the needs of our Patients, Payors, Providers and Pharma partners."

Dr. Patel is a registered pharmacist with over 10 years of operational and strategic development experience in the areas of Specialty, Home Infusion, and Pharmacy Technology. Prior to joining Diplomat she was the Director of Procurement & Pharma Relations at OptionCare; and at Caremark, Dr. Patel was the Manager of Contracts and Trade Relations and served as an IT Pharmacist. Dr. Patel is a graduate of the Bachelors in Pharmacy and Doctor of Pharmacy programs at Midwestern University in Downers Grove, Illinois.

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is the nation's largest independently held Specialty Pharmacy and focuses on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis, Crohn's and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio-Identical Hormone Replacement Therapy and Specialty Compounding. The company also specializes in Disease Management programs for Chronic Kidney Disease patients, as well as Home and Out-Patient Infusion. With locations in Flint, Swartz Creek and Grand Rapids, MI; Cleveland, OH; Chicago, IL; and Ft. Lauderdale, Florida; Diplomat services the specialty pharmacy needs of patients and physicians nationwide.

For more information contact:

Kathy Karns


SOURCE Diplomat Specialty Pharmacy
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Diplomats 2008 Patient Satisfaction Survey Sets the Bar for Specialty Pharmacy Industry
2. Diplomat Specialty Pharmacy Sponsors National Managed Care Roundtable for Industry Executive Advisory Board
3. Diplomat Specialty Pharmacy Hires National Accounts Manager to Expand Multiple Sclerosis Program
4. Diplomat Specialty Pharmacy Hires Vice President of Managed Markets
5. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
6. Stem Cell Transplantation Program at Hackensack University Medical Center: First in Nation to Receive Joint Commission Certification for Quality and First in New Jersey to be Named a Blue Distinction(R) Center for Specialty Care.
7. Anadys Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
8. Onyx Pharmaceuticals to Present at Bank of America 2008 Specialty Pharmaceuticals Conference
9. Idenix Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
10. A Perfect Storm Threatens Patient Access to Specialty Medical Care
11. 60 Specialty Chemical, Fine Chemical & Custom Synthesis Providers Will Exhibit at Pharma ChemOutsourcing on September 8-9 in New Jersey
Post Your Comments:
(Date:10/12/2017)... ... October 12, 2017 , ... ... announced today that they have entered into a multiyear collaboration to identify and ... researchers with additional tools for gene editing across all applications. , Under the ...
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, ... and biotechnology industries to improve patient outcomes and quality of life, will now ... testing are being attributed to new regulatory requirements for all new drug products, ...
(Date:10/11/2017)... LINDA, CA (PRWEB) , ... October 11, 2017 ... ... to upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding ... (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... ... 2017 , ... Proscia Inc ., a data solutions ... “Pathology is going digital. Is your lab ready?” with Dr. Nicolas Cacciabeve, Managing ... how Proscia improves lab economics and realizes an increase in diagnostic confidence.* ...
Breaking Biology Technology:
(Date:8/23/2017)... , Aug. 23, 2017  The general public,s help is being ... microbiome—the bacteria that live in and on the human body –and are ... The Microbiome ... the human microbiome, starting with the gut. The project's goal is to ... Photo credit: IBM ...
(Date:6/23/2017)... ARMONK, N.Y. and ITHACA, N.Y. ... IBM ) and Cornell University, a leader in dairy ... combined with bioinformatics designed to help reduce the chances ... breaches. With the onset of this dairy project, Cornell ... the Consortium for Sequencing the Food Supply Chain, a ...
(Date:5/16/2017)... , May 16, 2017   Bridge Patient ... organizations, and MD EMR Systems , an ... partner for GE, have established a partnership to ... product and the GE Centricity™ products, including Centricity ... These new integrations will allow ...
Breaking Biology News(10 mins):